Shares of Indian pharma companies with significant US exposure surged by up to 14% after President Trump refrained from ...
AM, all 20 Nifty Pharma constituents traded in the green. Among others, Gland Pharma was up 7.74 per cent, Lupin was up over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results